Pharma

2024 - 12 - 20

Post cover
Image courtesy of "PMLiVE"

Pro bono work in pharma - PMLiVE (PMLiVE)

For most of us working in healthcare communications, the best buzz is when the work has clearly reached those who are most in need of support.

Marco Prescribes $10 Million ABL Facility for Pharma Distributor ... (CFO Dive)

Marco has recently funded a $10 million Asset-Based Lending (ABL) revolving facility for a pharmaceutical wholesaler. PRESS RELEASE FROM MARCO.

Post cover
Image courtesy of "EURACTIV"

EU pharma package incentivises innovation in gap zones, says ... (EURACTIV)

A predictable regulatory environment that rewards pharmaceutical companies for developing innovative, high-value treatments is essential, said the Czech, ...

Post cover
Image courtesy of "EURACTIV"

Poland develops its first national critical medicines list, boosting ... (EURACTIV)

The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining pharmaceutical supplies in times of ...

Post cover
Image courtesy of "Business Wire"

Innate Pharma to Participate in the 43rd Annual J.P. Morgan ... (Business Wire)

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and.

Post cover
Image courtesy of "GlobeNewswire"

Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare ... (GlobeNewswire)

Tokyo, Japan and Cambridge, UK, 20 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei...

Post cover
Image courtesy of "Jamaica Gleaner"

Pharma firms aching (Jamaica Gleaner)

The three pharmaceutical companies listed on the Jamaica Stock Exchange are enduring pain. Two posted losses in their latest quarter, and the third missed ...

Pharma Shifts to Needle-Free Injectors: Microneedle Devices Set for ... (Business Wire)

The needle-free drug injection system market is expected to reach USD 606 million in the current year and is anticipated to grow at a CAGR of 4% to 2035.

Setback for UK pharma as government sets unexpectedly high ... (pharmaceutical-technology.com)

The UK's DHSC has announced its anticipated 2025 headline payback rate for new medicines under the 2024–2028 VPAG.

Post cover
Image courtesy of "PharmaLive"

Five data-driven media planning principles for pharma marketers in ... (PharmaLive)

When it comes to media strategy, the line between “spending” and “investing” can be as hazy as a misty morning. The difference? Spending is throwing money ...

Sorriso Pharma's UC treatment hits Phase Ib endpoints (Clinical Trials Arena)

Sorriso Pharmaceuticals announced that it is looking to move to Phase II after its ulcerative colitis treatment saw success over placebo.

Post cover
Image courtesy of "Pharmaceutical Executive"

Pharma Pulse 12/20/24: Trends in Enterprise Value Growth and ... (Pharmaceutical Executive)

Anna-Maria Hoffmann-Vold, MD, PhD, discusses progressive pulmonary fibrosis, its primary causes and the key risk factors contributing to its development and ...

Zealand Pharma CEO says Novo's CagriSema data supports ... (Reuters)

The CEO of Danish drugmaker Zealand Pharma said on Friday that data posted by Novo Nordisk's late-stage study of its next-generation obesity drug CagriSema ...

Post cover
Image courtesy of "Business Wire"

TME Pharma Provides Results of Fourth Exercise of Warrants Z (Business Wire)

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea.

Explore the last week